KR100295818B1 - 1-amino pyrrolidine derivatives and agricultural and hortic ultural resticide composition comprising same - Google Patents

1-amino pyrrolidine derivatives and agricultural and hortic ultural resticide composition comprising same Download PDF

Info

Publication number
KR100295818B1
KR100295818B1 KR1019980029469A KR19980029469A KR100295818B1 KR 100295818 B1 KR100295818 B1 KR 100295818B1 KR 1019980029469 A KR1019980029469 A KR 1019980029469A KR 19980029469 A KR19980029469 A KR 19980029469A KR 100295818 B1 KR100295818 B1 KR 100295818B1
Authority
KR
South Korea
Prior art keywords
alkyl
compound
atom
oil
och
Prior art date
Application number
KR1019980029469A
Other languages
Korean (ko)
Other versions
KR20000009203A (en
Inventor
연규환
류훈한
박창식
김진철
Original Assignee
김충섭
한국화학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김충섭, 한국화학연구원 filed Critical 김충섭
Priority to KR1019980029469A priority Critical patent/KR100295818B1/en
Publication of KR20000009203A publication Critical patent/KR20000009203A/en
Application granted granted Critical
Publication of KR100295818B1 publication Critical patent/KR100295818B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4021-aryl substituted, e.g. piretanide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

본 발명은 식물 병원균에 대한 살균력이 우수하고 광범위한 항균 스펙트럼을 갖는 하기 일반식(I)로 표시되는 1-아미노 피롤리딘 유도체 및 이를 포함하는 농원예용 살균제 조성물에 관한 것이다.The present invention relates to a 1-amino pyrrolidine derivative represented by the following general formula (I) having excellent bactericidal power against plant pathogens and having a broad antibacterial spectrum, and an agricultural and horticultural fungicide composition comprising the same.

(I) (I)

상기 식에서,Where

R1는 수소원자 또는 C1-C3알킬이고,R 1 is a hydrogen atom or C 1 -C 3 alkyl,

R2및 R3는 각각 독립적으로 수소원자, 할로겐원자 또는 C1-C3알킬이고,R 2 and R 3 are each independently a hydrogen atom, a halogen atom or C 1 -C 3 alkyl,

Q는또는이다Q is or to be

(여기서, R4는 C1-C3알킬이고,Wherein R 4 is C 1 -C 3 alkyl,

R5및 R6는 각각 독립적으로 수소 원자, 할로겐 원자, 페녹시, 벤질옥시, 또는 할로겐 원자, C1-C3알킬 또는 C1-C3알콕시로 치환된 벤질옥시이고,R 5 and R 6 are each independently hydrogen atom, halogen atom, phenoxy, benzyloxy, or benzyloxy substituted with halogen atom, C 1 -C 3 alkyl or C 1 -C 3 alkoxy,

R7는 C1-C3알킬이고,R 7 is C 1 -C 3 alkyl,

X는 산소 또는 황원자이고,X is oxygen or sulfur atom,

Y는 산소원자 또는 S(O)n이고,Y is an oxygen atom or S (O) n ,

n은 0, 1 또는 2이다).n is 0, 1 or 2).

Description

1-아미노 피롤리딘 유도체 및 이를 포함하는 농원예용 살균제 조성물{1-AMINO PYRROLIDINE DERIVATIVES AND AGRICULTURAL AND HORTIC ULTURAL RESTICIDE COMPOSITION COMPRISING SAME}1-amino pyrrolidine derivative and agricultural horticultural fungicide composition comprising the same

본 발명은 식물 병원균에 대한 살균력이 우수한 1-아미노 피롤리딘 유도체에 관한 것으로, 상세하게는 1-페닐아미노-피롤리딘-2,5-디온과 1-페닐아미노-1,3-디하이드로-피롤-2-온 유도체 및 이를 포함하는 농원예용 살균제 조성물에 관한 것이다.The present invention relates to a 1-amino pyrrolidine derivative having excellent bactericidal activity against plant pathogens, specifically 1-phenylamino-pyrrolidine-2,5-dione and 1-phenylamino-1,3-dihydro It relates to a pyrrole-2-one derivative and agrohorticultural germicide composition comprising the same.

종래, 1-페닐아미노-3-페닐-피롤리딘-2,5-디온 유도체는 진경련제의 약효가 보고된 바 있으나[M. J. Kornet,J. of Phermaceutical Science,73, 405(1984)], 식물 병원균에 대한 살균 작용에 대하여는 전혀 언급된 바 없다.Conventionally, 1-phenylamino-3-phenyl-pyrrolidine-2,5-dione derivatives have been reported to have an anticonvulsant effect [MJ Kornet, J. of Phermaceutical Science , 73 , 405 (1984)]. There is no mention of bactericidal activity against pathogens.

한편 다수의 트리아졸 또는 이미다졸 유도체가 살균 또는 항진균 작용을 갖는 것으로 알려지고 있으며, 대한민국 특허출원 제 97-14844 호에는 3-아릴-2-(1,2,4-트리아졸-1-일)-퀴놀린과 3-아릴-2-(1,3-이미다졸-1-일)-퀴놀린, 3-아릴-2-(1,2,4-트리아졸-1-일)-1H-퀴놀린-4-온과3-아릴-2-(1,3-이미다졸-1-일)-1H-퀴놀린-4-온이 개시되어 있다.On the other hand, a number of triazoles or imidazole derivatives are known to have bactericidal or antifungal action, and Korean Patent Application No. 97-14844 discloses 3-aryl-2- (1,2,4-triazol-1-yl). -Quinoline with 3-aryl-2- (1,3-imidazol-1-yl) -quinoline, 3-aryl-2- (1,2,4-triazol-1-yl) -1H-quinoline-4 -One and 3-aryl-2- (1,3-imidazol-1-yl) -1H-quinolin-4-one are disclosed.

그러나, 상기 화합물의 살균 작용은 아직 충분하지 못하며, 보다 우수한 활성을 가진 화합물들이 여전히 필요하다.However, the bactericidal action of the compound is not yet sufficient, and compounds with better activity are still needed.

본 발명의 목적은 식물 병원균에 대해 살균력이 우수한 1-아미노 피롤리딘 유도체를 제공하는 것이다.It is an object of the present invention to provide 1-amino pyrrolidine derivatives which are excellent in bactericidal activity against plant pathogens.

본 발명의 다른 목적은 상기 화합물을 포함하는 농원예용 살균제 조성물을 제공하는 것이다.It is another object of the present invention to provide a horticultural fungicide composition comprising the compound.

상기 목적에 따라, 본 발명에서는 하기 일반식(I)로 표시되는 1-아미노 피롤리딘 유도체를 제공한다.In accordance with the above object, the present invention provides a 1-amino pyrrolidine derivative represented by the following general formula (I).

화학식 1Formula 1

(I) (I)

상기 식에서,Where

R1는 수소원자 또는 C1-C3알킬이고,R 1 is a hydrogen atom or C 1 -C 3 alkyl,

R2및 R3는 각각 독립적으로 수소원자, 할로겐원자 또는 C1-C3알킬이고,R 2 and R 3 are each independently a hydrogen atom, a halogen atom or C 1 -C 3 alkyl,

Q는또는이다Q is or to be

(여기서, R4는 C1-C3알킬이고,Wherein R 4 is C 1 -C 3 alkyl,

R5및 R6는 각각 독립적으로 수소 원자, 할로겐 원자, 페녹시, 벤질옥시, 또는 할로겐 원자, C1-C3알킬 또는 C1-C3알콕시로 치환된 벤질옥시이고,R 5 and R 6 are each independently hydrogen atom, halogen atom, phenoxy, benzyloxy, or benzyloxy substituted with halogen atom, C 1 -C 3 alkyl or C 1 -C 3 alkoxy,

R7는 C1-C3알킬이고,R 7 is C 1 -C 3 alkyl,

X는 산소 또는 황원자이고,X is oxygen or sulfur atom,

Y는 산소원자 또는 S(O)n이고,Y is an oxygen atom or S (O) n ,

n은 0, 1 또는 2이다).n is 0, 1 or 2).

또한 본 발명에서는 상기 일반식(I)의 화합물 살균효과량과 약제학적으로 허용되는 고체 또는 액체 담체를 포함하는 농원예용 살균제 조성물을 제공한다.In another aspect, the present invention provides a horticultural germicide composition comprising a compound bactericidal effective amount of the general formula (I) and a pharmaceutically acceptable solid or liquid carrier.

이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명에 따른 일반식(I)의 화합물에서 Q가인 1-페닐아미노-피롤리딘-2,5-디온 유도체의 예는 하기 표 1과 같다.Q in the compound of formula (I) according to the invention Examples of phosphorus 1-phenylamino-pyrrolidine-2,5-dione derivatives are shown in Table 1 below.

화합물compound R1 R 1 R2 R 2 R3 R 3 R4 R 4 R5 R 5 R6 R 6 XX mp(oC)mp ( o C) 1One HH HH 2'-F2'-F MeMe HH HH OO 22 HH HH 2'-F2'-F MeMe HH HH SS 33 HH HH 4'-F4'-F MeMe HH HH OO 44 HH HH 4'-F4'-F MeMe HH HH SS 55 HH HH 2'-Me2'-Me MeMe HH HH OO 66 HH HH 2'-Me2'-Me MeMe HH HH SS 77 HH 2'-Me2'-Me 4'-Cl4'-Cl MeMe HH HH OO 88 HH 2'-Me2'-Me 4'-Cl4'-Cl MeMe HH HH SS 99 HH HH HH MeMe HH 4-F4-F OO 1010 HH HH HH MeMe HH 4-F4-F SS 1111 MeMe HH HH MeMe HH 4-F4-F OO 1212 MeMe HH HH MeMe HH 4-F4-F SS 1313 HH HH HH MeMe HH 4-Cl4-Cl OO 118-119118-119 1414 HH HH HH MeMe HH 4-Cl4-Cl SS 오일oil 1515 MeMe HH HH MeMe HH 4-Cl4-Cl OO 오일oil 1616 HH HH 4'-Cl4'-Cl MeMe HH 4-Cl4-Cl OO 1717 HH HH HH MeMe HH 4-Br4-Br OO 1818 HH HH HH MeMe HH 4-Br4-Br SS 오일oil 1919 MeMe HH HH MeMe HH 4-Br4-Br OO 오일oil 2020 MeMe HH HH MeMe HH 4-Br4-Br SS 오일oil 2121 HH HH HH MeMe HH 4-OPh4-OPh OO 오일oil 2222 HH HH HH MeMe HH 4-OPh4-OPh SS 오일oil 2323 MeMe HH HH MeMe HH 4-OPh4-OPh OO 오일oil 2424 MeMe HH HH MeMe HH 4-OPh4-OPh SS 오일oil 2525 HH HH HH MeMe HH 4-OCH2Ph4-OCH 2 Ph OO 오일oil 2626 HH HH HH MeMe HH 4-OCH2Ph4-OCH 2 Ph SS 오일oil 2727 MeMe HH HH MeMe HH 4-OCH2Ph4-OCH 2 Ph OO 152-153152-153 2828 MeMe HH HH MeMe HH 4-OCH2Ph4-OCH 2 Ph SS 오일oil 2929 HH HH HH MeMe HH 4-OCH2Ph(4-F)4-OCH 2 Ph (4-F) OO 오일oil 3030 HH HH HH MeMe HH 4-OCH2Ph(4-F)4-OCH 2 Ph (4-F) SS 오일oil 3131 MeMe HH HH MeMe HH 4-OCH2Ph(4-F)4-OCH 2 Ph (4-F) OO 오일oil 3232 MeMe HH HH MeMe HH 4-OCH2Ph(4-F)4-OCH 2 Ph (4-F) SS 오일oil 3333 HH HH HH MeMe HH 4-OCH2Ph(2-Cl)4-OCH 2 Ph (2-Cl) OO 131-132131-132 3434 HH HH HH MeMe HH 4-OCH2Ph(2-Cl)4-OCH 2 Ph (2-Cl) SS 오일oil

화합물compound R1 R 1 R2 R 2 R3 R 3 R4 R 4 R5 R 5 R6 R 6 XX mp(oC)mp ( o C) 3535 MeMe HH HH MeMe HH 4-OCH2Ph(2-Cl)4-OCH 2 Ph (2-Cl) OO 67-6867-68 3636 MeMe HH HH MeMe HH 4-OCH2Ph(2-Cl)4-OCH 2 Ph (2-Cl) SS 오일oil 3737 HH HH HH MeMe HH 4-OCH2Ph(2-Br)4-OCH 2 Ph (2-Br) OO 3838 HH HH HH MeMe HH 4-OCH2Ph(2-Br)4-OCH 2 Ph (2-Br) SS 오일oil 3939 MeMe HH HH MeMe HH 4-OCH2Ph(2-Br)4-OCH 2 Ph (2-Br) OO 오일oil 4040 MeMe HH HH MeMe HH 4-OCH2Ph(2-Br)4-OCH 2 Ph (2-Br) SS 오일oil 4141 HH HH HH MeMe HH 4-OCH2Ph(2-Me)4-OCH 2 Ph (2-Me) OO 오일oil 4242 HH HH HH MeMe HH 4-OCH2Ph(2-Me)4-OCH 2 Ph (2-Me) SS 오일oil 4343 MeMe HH HH MeMe HH 4-OCH2Ph(2-Me)4-OCH 2 Ph (2-Me) OO 오일oil 4444 MeMe HH HH MeMe HH 4-OCH2Ph(2-Me)4-OCH 2 Ph (2-Me) SS 오일oil 4545 HH HH HH MeMe HH 4-OCH2Ph(3-Me)4-OCH 2 Ph (3-Me) OO 4646 HH HH HH MeMe HH 4-OCH2Ph(3-Me)4-OCH 2 Ph (3-Me) SS 오일oil 4747 MeMe HH HH MeMe HH 4-OCH2Ph(3-Me)4-OCH 2 Ph (3-Me) OO 4848 MeMe HH HH MeMe HH 4-OCH2Ph(3-Me)4-OCH 2 Ph (3-Me) SS 4949 HH HH HH MeMe HH 4-OCH2Ph(3-OMe)4-OCH 2 Ph (3-OMe) OO 오일oil 5050 HH HH HH MeMe HH 4-OCH2Ph(3-OMe)4-OCH 2 Ph (3-OMe) SS 오일oil 5151 MeMe HH HH MeMe HH 4-OCH2Ph(3-OMe)4-OCH 2 Ph (3-OMe) OO 오일oil 5252 MeMe HH HH MeMe HH 4-OCH2Ph(3-OMe)4-OCH 2 Ph (3-OMe) SS 오일oil 5353 HH HH HH MeMe 2-Cl2-Cl 4-Cl4-Cl OO 오일oil 5454 HH HH HH MeMe 2-Cl2-Cl 4-Cl4-Cl SS 오일oil 5555 MeMe HH HH MeMe 2-Cl2-Cl 4-Cl4-Cl OO 오일oil 5656 MeMe HH HH MeMe 2-Cl2-Cl 4-Cl4-Cl SS 오일oil

또한, 일반식(I)의 화합물에서 Q가인 1-페닐아미노-1,3-디하이드로-피롤-2-온 유도체의 예는 하기 표 2와 같다.In addition, Q in the compound of general formula (I) Examples of phosphorus 1-phenylamino-1,3-dihydro-pyrrole-2-one derivatives are shown in Table 2 below.

화합물compound R1 R 1 R2 R 2 R3 R 3 R4 R 4 R5 R 5 R6 R 6 R7 R 7 YY mp(oC)mp ( o C) 5757 HH HH HH MeMe HH 4-Cl4-Cl MeMe SS 5858 MeMe HH HH MeMe HH 4-Cl4-Cl MeMe SS 5959 MeMe HH HH MeMe HH 4-Cl4-Cl MeMe SO2 SO 2 6060 HH HH HH MeMe HH 4-Br4-Br MeMe SS 6161 MeMe HH HH MeMe HH 4-Br4-Br MeMe SS 6262 MeMe HH HH MeMe HH 4-OPh4-OPh MeMe SS 6363 HH HH HH MeMe HH 4-OCH2Ph(2-Me)4-OCH 2 Ph (2-Me) MeMe SS 6464 MeMe HH HH MeMe HH 4-OCH2Ph(2-Me)4-OCH 2 Ph (2-Me) MeMe SS 6565 MeMe HH HH MeMe HH 4-OCH2Ph(3-OMe)4-OCH 2 Ph (3-OMe) MeMe SS 6666 MeMe HH HH MeMe 2-Cl2-Cl 4-Cl4-Cl MeMe SS

본 발명의 화합물(I)은 하기 반응 도식에 따라 제조할 수 있다.Compound (I) of the present invention can be prepared according to the following reaction scheme.

상기 식에서,Where

R1, R2, R3, R4, R5, R6및 R7는 상기 정의한 바와 같고, m은 1 또는 2이다.R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are as defined above and m is 1 or 2.

상기 일반식(I)의 화합물의 제조방법을 단계별로 설명하면 다음과 같다.Referring to the preparation method of the compound of the general formula (I) step by step.

(단계 1)(Step 1)

페닐아세테이트 유도체(II)를 염기 존재하에 할로겐화알킬로 알킬화 반응시켜 화합물(III)을 얻는다. 이때, 염기로는 소디움 하이드라이드, 포타슘 t-부톡사이드, 리튬 비스트리메틸실릴아미드, 리튬 디이소프로필아미드등을 사용할 수 있고, 반응용매로는 디메틸포름아미드, 테트라하이드로퓨란, 에틸에테르, 디메틸술폭사이드 등을 사용할 수 있으며 바람직하게는 디메틸포름아미드이고, 반응온도는 0 내지 40℃이다. 수율은 90 내지 98%이다.The phenylacetate derivative (II) is alkylated with an alkyl halide in the presence of a base to give compound (III). At this time, sodium hydride, potassium t-butoxide, lithium bistrimethylsilylamide, lithium diisopropylamide, etc. may be used as a base, and as a reaction solvent, dimethylformamide, tetrahydrofuran, ethyl ether, dimethyl sulfoxide Etc. can be used, Preferably it is dimethylformamide, and reaction temperature is 0-40 degreeC. Yield is 90-98%.

(단계 2)(Step 2)

화합물(III)을 염기 존재하에 메틸브로모아세테이트로 알킬화 반응시켜 화합물(IV)을 얻는다. 이때, 염기, 반응용매 및 반응온도 등의 반응조건은 단계 1과 동일하며, 수율은 40 내지 60%이다.Compound (III) is alkylated with methylbromoacetate in the presence of a base to give compound (IV). At this time, the reaction conditions such as base, reaction solvent and reaction temperature are the same as in step 1, the yield is 40 to 60%.

(단계 3)(Step 3)

화합물(IV)을 염기성 조건하에 가수분해 반응시켜 화합물(V)를 얻는다. 이때 염기로는 수산화칼륨, 수산화나트륨 등을 사용할 수 있고, 반응용매로는 물 또는 알콜을 사용할 수 있으며, 반응액을 환류시켜 고수율로 화합물(V)을 얻을 수 있다.Compound (IV) is hydrolyzed under basic conditions to give compound (V). At this time, potassium hydroxide, sodium hydroxide, etc. may be used as the base, water or alcohol may be used as the reaction solvent, and the reaction solution may be refluxed to obtain a compound (V) in high yield.

(단계 4)(Step 4)

화합물(V)을 페닐하이드라진 존재하에 아세트산, 프로피온산 등의 유기산 또는, 크실렌, 디클로로벤젠 등의 방향족 유기용매에서 환류시켜 본 발명의 화합물(Ia)을 직접 얻을 수 있다.Compound (V) can be directly refluxed in an organic acid such as acetic acid or propionic acid or aromatic organic solvent such as xylene or dichlorobenzene in the presence of phenylhydrazine to directly obtain compound (Ia) of the present invention.

또다른 방법으로, 화합물(V)을 아세틸클로라이드에서 환류시켜 퓨란디온 화합물을 얻은 후 페닐하이드라진 존재하에 아세트산 용매에서 환류시키는 두 단계를 거쳐 본 발명의 화합물(Ia)를 얻을 수도 있다.Alternatively, compound (I) of the present invention may be obtained by two steps of refluxing compound (V) in acetyl chloride to obtain a furandione compound and then refluxing in acetic acid solvent in the presence of phenylhydrazine.

(단계 5)(Step 5)

화합물(Ia)을 로슨시약과 함께 벤젠, 톨루엔 등의 방향족 유기용매에서 환류시켜, 산소원자가 황원자로 치환된 본 발명의 화합물(Ib)을 고수율로 얻을 수 있다.Compound (Ia) is refluxed in an aromatic organic solvent such as benzene and toluene together with a Lawson reagent to obtain compound (Ib) of the present invention in which the oxygen atom is substituted with a sulfur atom in high yield.

(단계 6)(Step 6)

화합물(Ia)을 염기 존재하에 할로겐화알킬과 알킬화 반응시켜 본 발명의 화합물(Ic)을 얻는다. 이때, 염기로는 소디움 하이드라이드, 포타슘 t-부톡사이드, 부틸 리튬 등을 사용할 수 있고, 반응용매로는 디메틸포름아미드, 테트라하이드로퓨란 등을 사용할 수 있으며, 반응 온도는 -20 내지 40℃이다.Compound (Ia) is alkylated with an alkyl halide in the presence of a base to give compound (Ic) of the present invention. In this case, sodium hydride, potassium t-butoxide, butyl lithium, etc. may be used as the base, dimethylformamide, tetrahydrofuran, etc. may be used as the reaction solvent, and the reaction temperature is -20 to 40 ° C.

(단계 7)(Step 7)

화합물(Ia) 대신에 화합물(Ib)을 사용한다는 점을 제외하고는 단계 6과 동일한 방법으로 알킬화 반응을 수행하여, 본 발명의 화합물(Id)을 얻는다.The alkylation reaction was carried out in the same manner as in Step 6 except that Compound (Ib) was used instead of Compound (Ia), to obtain Compound (Id) of the present invention.

(단계 8)(Step 8)

화합물(Id)을 산화제가 포함된 유기용매중에서 산화반응시켜 본 발명의 화합물(Ie)을 얻는다. 이때, 산화제로는 과산화수소, 과산화아세트산, 과산화벤조산, 옥손 등의 통상적인 산화제를 사용할 수 있으며, 유기용매로는 디클로로메탄, 클로로포름 등의 할로겐용매, 메탄올, 에탄올 등의 알콜, 아세트산 등을 사용할 수 있고, 반응 온도는 0 내지 110℃이다.Compound (Id) is oxidized in an organic solvent containing an oxidizing agent to obtain compound (Ie) of the present invention. In this case, as the oxidizing agent, conventional oxidizing agents such as hydrogen peroxide, acetic acid peroxide, benzoic acid peroxide, oxone, and the like may be used, and as the organic solvent, halogen solvents such as dichloromethane and chloroform, alcohols such as methanol and ethanol, acetic acid and the like may be used , Reaction temperature is 0-110 degreeC.

본 발명의 일반식(I)의 화합물은 통상의 방법에 따라 산부가염으로 전환시킬 수 있다. 이러한 산부가염의 예로는 제제상 허용되는 산, 예를 들면 염산, 황산, 질산, 브롬화수소산 등의 무기산, 또는 아세트산, 옥살산, 푸말산, 말레인산, 시트르산 등의 유기산의 산부가염을 들 수 있다.Compounds of formula (I) of the present invention can be converted to acid addition salts according to conventional methods. Examples of such acid addition salts include acid acceptable salts of preparations such as inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid and hydrobromic acid, or organic acids such as acetic acid, oxalic acid, fumaric acid, maleic acid and citric acid.

상기 일반식(I)의 화합물은 다양한 식물 병원균에 대하여 월등한 살균 작용을 가지고 있어, 이 병원균에 의해 발생되는 질병의 억제와 박멸에 사용될 수 있다. 특히 일반식(I)의 화합물은 벼에 심각한 질병인, 벼잎집무늬 마름병(Rhizoctonia solani) 및 벼도열병(Pyricularia oryzae) 등에 현저한 작용이 있으며, 다음의 농작물 질병, 즉 균핵고조병(Corticium centrifugum), 벼 흰빛잎 마름병(Xanthomonas oryzae), 중국 양배추 무름병(Erwinia aroideae), 궤양병(Xanthomonas citri), 벼 호마엽고병(Cochliobolus miyabeanus), 바나나 반점(Mycosphaerella musicola), 오이 및 딸기의 회색곰팡이병(Botrytis cinerea), 포도노균병(Plasmopara viticola), 포도, 사과 및 배의 혹두병(Glomella cingulata), 채소의 흰비단병(Sclerotinia sclerotiorum), 참외의 탄저병(Colletotrichum lagenarium), 수지병(Diaporthe citri), 사과 백분병(Podosphaera leucotricha), 오이 백분병(Sphaerotheca fuliginea), 사과반점(Alternaria mali)과 같은 감자겹 둥근 무늬병(Alternaria solani) 및 배흑반(Alternaria kikuchiana)같은 흑반, 그리고 사과 흑성병(Venturia inaequalis) 및 배흑성병 같은 흑성병에도 유효하다.The compound of general formula (I) has a superior bactericidal action against various plant pathogens, and can be used for suppression and eradication of diseases caused by this pathogen. In particular, the compound of formula (I) has a remarkable effect on rice, Rhizoctonia solani and Pyricularia oryzae , which are serious diseases of rice, and have the following crop diseases: Corticium centrifugum , Rice white leaf blight ( Xanthomonas oryzae ), Chinese cabbage soft rot ( Erwinia aroideae ), ulcer disease ( Xanthomonas citri ), rice hoebi ( Cochliobolus miyabeanus ), banana spot ( Mycosphaerella musicola ), cucumber and strawberry gray fungus ( Botrytis cinerea ) Plasmopara viticola , Glomella cingulata of grapes, apples, and pears, Sclerotinia sclerotiorum of vegetables, Colletotrichum lagenarium , Diaporthe citri , and Podosphaera such leucotricha), cucumber mildew (Sphaerotheca fuliginea), apples spot (Alternaria mali) and folds, such as potatoes rounded blotch (Alternaria solani) and fold heukban (Alternaria kikuchiana) Half, and Apple is also effective as heukseongbyeong (Venturia inaequalis) and pears heukseongbyeong heukseongbyeong.

따라서, 본 발명에서는 유효량의 일반식(I)의 화합물 및 이의 약제학적으로 허용가능한 염과 약제학적으로 허용되는 고체 또는 액체 담체를 포함하는 농원예용 살균제 조성물을 제공한다.Accordingly, the present invention provides agrohorticultural fungicide compositions comprising an effective amount of a compound of formula (I) and a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable solid or liquid carrier.

본 발명에 따른 살균활성 화합물(I)은 용액, 유탁액, 수화제, 현탁액, 분말, 분제, 기포제, 파스타제, 용성분말, 입제, 에어로졸, 유제, 종자처리용 분말, 활성화합물로 포화된 천연 및 합성물질, 중합한 물질 중의 매우 미세한 캅셀제, 종자용 피막 조성물, 그리고 훈증카아트리지(cartridge), 훈증캔, 훈증코일 및 ULV 냉무 및 온무제제 등의 가열장치로 사용되는 제제로 전환시켜 사용할 수 있다. 이러한 제제는 활성화합물을 액체 또는 액화된 기체 또는 고체 희석제 또는 담체 등의 중량제와 혼합하는 공지의 방법으로 제조할 수 있으며, 이 때 임의로 유화제 및 분산제 또는 기포제 등의 계면활성제를 사용할 수 있다. 또한 중량제로 물을 사용할 경우 유기 용매를 보조 용매로 사용할 수 있다. 본 발명의 화합물(I)은 제형에 따라 0.1 내지 95%의 양으로 사용할 수 있다.The bactericidal active compound (I) according to the present invention is a solution, emulsion, wetting agent, suspension, powder, powder, foaming agent, pasta, solvent powder, granule, aerosol, emulsion, powder for seed treatment, natural saturated with active compound and It can be used by converting it into a composition used in heating devices such as synthetic materials, very fine capsules in polymerized materials, seed coating compositions, and fumigation cartridges, fumigation cans, fumigation coils, and ULV cold misting and warming agents. . Such formulations may be prepared by known methods for mixing the active compound with a weighting agent such as liquid or liquefied gas or solid diluents or carriers, and optionally surfactants such as emulsifiers and dispersants or foaming agents may be used. In addition, when water is used as a weighting agent, an organic solvent may be used as an auxiliary solvent. Compound (I) of the present invention may be used in an amount of 0.1 to 95% depending on the formulation.

이하, 제조예 및 실시예에 의하여 본 발명을 더욱 상세히 설명하나, 본 발명이 이에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Preparation Examples and Examples, but the present invention is not limited thereto.

제조예 1: 메틸 2-(4-클로로페닐)프로파노에이트의 제조Preparation Example 1 Preparation of Methyl 2- (4-chlorophenyl) propanoate

질소분위기하에서 무수 디메틸포름아미드 500 ml에 60% 소디움 하이드라이드 13.1 g(328 mmol)을 넣고 0 ℃로 냉각한 후 교반하면서 메틸 2-(4-클로로페닐)아세테이트 50 g(271 mmol)을 적가하고 상온에서 1시간동안 교반하였다. 이어서, 반응물을 0 ℃로 냉각한 후 요오드메탄 42.3 g(328 mmol)을 적가하고 상온에서 1시간동안 교반하였다. 반응물을 얼음물 1000 ml에 가하고 디클로로메탄 200 ml로 2회 추출하였다. 유기층을 무수 황산나트륨으로 건조시키고 여과하여 농축하였다. 생성물을 칼럼 크로마토그래피(용출액,n-헥산:에틸아세테이트=6:1)로 정제하여 표제화합물 50.0g(수율 93 %)를 얻었다.Under nitrogen atmosphere, 13.1 g (328 mmol) of 60% sodium hydride was added to 500 ml of anhydrous dimethylformamide, cooled to 0 ° C., and 50 g (271 mmol) of methyl 2- (4-chlorophenyl) acetate was added dropwise while stirring. Stirred at room temperature for 1 hour. The reaction was then cooled to 0 ° C. and then 42.3 g (328 mmol) of iodine methane were added dropwise and stirred at room temperature for 1 hour. The reaction was added to 1000 ml of ice water and extracted twice with 200 ml of dichloromethane. The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated. The product was purified by column chromatography (eluent, n-hexane: ethyl acetate = 6: 1) to give 50.0 g (yield 93%) of the title compound.

제조예 2: 디메틸 2-(4-클로로페닐)-2-메틸 숙시네이트의 제조Preparation Example 2 Preparation of Dimethyl 2- (4-Chlorophenyl) -2-methyl Succinate

질소분위기하에서 60% 무수 디메틸포름 아미드 500 ml에 소디움 하이드라이드 10.7 g(267 mmol)을 넣고 0 ℃로 냉각시킨 후 교반하면서 상기 제조예 1에서 얻은 화합물 52.4 g(264 mmol)을 적가하고 상온에서 18시간동안 교반하였다. 이어서, 반응물을 0 ℃로 냉각한 후 메틸브로모아세테이트 40.7 g(267 mmol)을 적가하고 상온에서 1시간동안 교반하였다. 반응물을 얼음물 1000 ml에 가하고 디클로로메탄 200 ml로 2회 추출하였다. 유기층을 무수 황산나트륨으로 건조시키고 여과하여 농축 하였다. 생성물을 칼럼 크로마토그래피(용출액,n-헥산:에틸아세테이트=3:1)로 정제하여 표제화합물 50.7 g(수율 71 %)를 얻었다.In a nitrogen atmosphere, 10.7 g (267 mmol) of sodium hydride was added to 500 ml of 60% anhydrous dimethylformamide, cooled to 0 ° C., and 52.4 g (264 mmol) of the compound obtained in Preparation Example 1 was added dropwise with stirring, followed by 18 at room temperature. Stir for hours. The reaction was then cooled to 0 ° C. and then 40.7 g (267 mmol) of methylbromoacetate was added dropwise and stirred at room temperature for 1 hour. The reaction was added to 1000 ml of ice water and extracted twice with 200 ml of dichloromethane. The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated. The product was purified by column chromatography (eluent, n-hexane: ethyl acetate = 3: 1) to give 50.7 g (71% yield) of the title compound.

제조예 3: 디메틸 2-(4-클로로페닐)-2-메틸 숙신산의 제조Preparation Example 3 Preparation of Dimethyl 2- (4-Chlorophenyl) -2-methyl Succinic Acid

상기 제조예 3에서 얻은 화합물 30.7 g(113 mmol)을 메탄올 300 ml에 녹이고 85% 수산화칼륨 22.5 g(340 mmol)을 물 50 ml에 녹인 용액을 적가한 후 100 내지 120 ℃에서 환류하면서 4 시간 교반하였다. 생성물을 100 ml 정도로 농축하고 얼음물 500 ml를 가한 후 10 % 염산을 가하여 pH 5가 되도록 하여 흰색 고체의 생성물을 얻었다. 이 생성물을 감압 여과한후 건조시켜 표제화합물 23.6 g(수율 86%)을 얻었다.30.7 g (113 mmol) of the compound obtained in Preparation Example 3 was dissolved in 300 ml of methanol, and a solution of 22.5 g (340 mmol) of 85% potassium hydroxide in 50 ml of water was added dropwise, followed by stirring at reflux at 100 to 120 ° C. for 4 hours. It was. The product was concentrated to about 100 ml, 500 ml of ice water was added, and 10% hydrochloric acid was added to pH 5 to obtain a white solid product. The product was filtered under reduced pressure and dried to give 23.6 g (yield 86%) of the title compound.

실시예 1: 1-페닐아미노-3-(4-클로로페닐)-3-메틸-피롤리딘-2,5-디온(표 1의 화합물 13)의 제조Example 1 Preparation of 1-phenylamino-3- (4-chlorophenyl) -3-methyl-pyrrolidine-2,5-dione (compound 13 in Table 1)

질소분위기하에서 상기 제조예 3에서 얻은 화합물 5.00 g(20.6 mmol)에 아세틸클로라이드 10 ml를 가한 후 교반하면서 50 내지 60℃에서 1시간동안 환류하였다. 이어서 반응물을 감압증류하여 아세틸클로라이드를 제거한 후, 생성된 3-(4-클로로페닐)-3-메틸테트라히드로-2,5-퓨란 디온 화합물을 별도의 정제단계 없이 바로 사용하였다.10 ml of acetyl chloride was added to 5.00 g (20.6 mmol) of the compound obtained in Preparation Example 3 under a nitrogen atmosphere, and the mixture was refluxed at 50 to 60 ° C. for 1 hour while stirring. The reaction was then distilled under reduced pressure to remove acetyl chloride, and the resulting 3- (4-chlorophenyl) -3-methyltetrahydro-2,5-furan dione compound was used directly without further purification.

얻어진 3-(4-클로로페닐)-3-메틸테트라히드로-2,5-퓨란 디온 화합물 4.7g을 아세트산 50 ml에 가하고 페닐히드라진 2.45 g(22.7 mmol)을 가한 후 120 내지 140℃ 온도에서 1시간동안 환류하였다. 반응물을 감압증류하여 아세트산을 제거하고 크실렌을 가한 후 단순증류하였다. 생성물에 대해 별도의 처리없이 칼럼 크로마토그래피(용출액,n-헥산:에틸아세테이트=3:1)를 실시하여 표제화합물 5.38 g(수율83%)을 얻었다.4.7 g of the obtained 3- (4-chlorophenyl) -3-methyltetrahydro-2,5-furandione compound was added to 50 ml of acetic acid and 2.45 g (22.7 mmol) of phenylhydrazine was added, followed by 1 hour at a temperature of 120 to 140 ° C. At reflux. The reaction was distilled under reduced pressure to remove acetic acid, xylene was added and then distilled briefly. The product was subjected to column chromatography (eluent, n-hexane: ethyl acetate = 3: 1) without further treatment to give 5.38 g (yield 83%) of the title compound.

1H NMR (200MHz, CDCl3) δ 7.33 (s, 4H, aromatic), 7.28-7.16 (m, 2H, aromatic), 6.99-6.90 (m, 1H, aromatic), 6.72-6.67(m, 2H, aromatic), 2.95 (dd, J= 50.6, 18.8 Hz, 2H, CH2), 1.60 (s, 3H, Me). 1 H NMR (200 MHz, CDCl 3) δ 7.33 (s, 4H, aromatic), 7.28-7.16 (m, 2H, aromatic), 6.99-6.90 (m, 1H, aromatic), 6.72-6.67 (m, 2H, aromatic) , 2.95 (dd, J = 50.6, 18.8 Hz, 2H, CH 2 ), 1.60 (s, 3H, Me).

실시예 2: 1-페닐아미노-3-(4-클로로페닐)-3-메틸-5-티옥소-피롤리딘-2-온(화합물 14)의 제조Example 2: Preparation of 1-phenylamino-3- (4-chlorophenyl) -3-methyl-5-thioxo-pyrrolidin-2-one (Compound 14)

질소분위기하에서 상기 실시예 1에서 얻은 화합물 1.50 g(4.76 mmol)과 로슨시약 2.12 g(5.24 mmol)에 무수 벤젠 15 ml를 가한 후 교반하면서 4시간동안 환류하였다. 반응물에 별도의 처리없이 직접 칼럼 크로마토그래피(용출액,n-헥산:에틸아세테이트=3:1)를 실시하여 표제화합물 1.43 g(수율 91%)을 얻었다.Under nitrogen atmosphere, 15 ml of anhydrous benzene was added to 1.50 g (4.76 mmol) of the compound obtained in Example 1 and 2.12 g (5.24 mmol) of Lawson reagent, followed by reflux for 4 hours with stirring. Directly performing column chromatography (eluent, n-hexane: ethyl acetate = 3: 1) on the reaction product was carried out to obtain 1.43 g (yield 91%) of the title compound.

1H NMR (200MHz, CDCl3) δ 7.35 (s, 4H, aromatic), 7.30-7.17 (m, 2H, aromatic), 7.03-6.95 (m, 1H, aromatic), 6.77-6.73 (m, 2H, aromatic), 2.99 (ddd, J= 56.2, 19.2, 1.0 Hz, 2H, CH2), 1.76 (s, 3H, Me). 1 H NMR (200MHz, CDCl3) δ 7.35 (s, 4H, aromatic), 7.30-7.17 (m, 2H, aromatic), 7.03-6.95 (m, 1H, aromatic), 6.77-6.73 (m, 2H, aromatic) , 2.99 (ddd, J = 56.2, 19.2, 1.0 Hz, 2H, CH 2 ), 1.76 (s, 3H, Me).

실시예 3 : 3-(4-클로로페닐)-3-메틸-1-(메틸-페닐-아미노)-5-메틸설파닐-2,3-디하이드로-피롤-2-온(화합물 59)의 제조Example 3 of 3- (4-chlorophenyl) -3-methyl-1- (methyl-phenyl-amino) -5-methylsulfanyl-2,3-dihydro-pyrrol-2-one (compound 59) Produce

질소분위기하에서 무수 디메틸포름아미드 30 ml에 60% 소디움 하이드라이드725 mg (18.1 mmol)를 넣고 0℃로 냉각시킨 후 교반하면서 상기 실시예 2에서 얻은 화합물 3.00 g(9.06 mmol)을 적가하고 상온에서 1시간동안 교반하였다. 반응물을 다시 0℃로 냉각한 후 요오드메탄 2.55 g(18.1 mmol)을 가하고 상온에서 1시간동안 교반하였다. 생성물을 얼음물 200 ml에 가하고 디클로로메탄으로 추출하였다. 추출액을 무수 황산나트륨으로 탈수 및 농축한 후 칼럼 크로마토그래피(용출액,n-헥산:에틸아세테이트=2:1)로 정제하여 표제화합물 1.76 g(수율 54%)를 얻었다.725 mg (18.1 mmol) of 60% sodium hydride was added to 30 ml of anhydrous dimethylformamide in a nitrogen atmosphere, cooled to 0 ° C., and 3.00 g (9.06 mmol) of the compound obtained in Example 2 was added dropwise with stirring to room temperature. Stir for hours. After the reaction was cooled to 0 ° C., 2.55 g (18.1 mmol) of iodine methane was added thereto, and the resultant was stirred at room temperature for 1 hour. The product was added to 200 ml of ice water and extracted with dichloromethane. The extract was dehydrated and concentrated with anhydrous sodium sulfate, and then purified by column chromatography (eluent, n-hexane: ethyl acetate = 2: 1) to obtain 1.76 g (54% yield) of the title compound.

1H NMR(200MHz, CDCl3) δ 7.54-7.11(m, 5H, aromatic), 6.98-6.67 (m, 4H, aromatic), 5.16 (s, 1H), 5.13 (s, 1H), 3.26 (d, J= 11Hz, 3H, N-Me), 2.31 (s, 3H, S-Me), 1.62 (s, 3H, Me) 1 H NMR (200 MHz, CDCl 3) δ 7.54-7.11 (m, 5H, aromatic), 6.98-6.67 (m, 4H, aromatic), 5.16 (s, 1H), 5.13 (s, 1H), 3.26 (d, J = 11 Hz, 3H, N-Me), 2.31 (s, 3H, S-Me), 1.62 (s, 3H, Me)

실시예 4 : 3-(4-클로로페닐)-3-메틸-1-(메틸-페닐-아미노)-5-메틸설포닐-2,3-디하이드로-피롤-2-온(화합물 60)의 제조Example 4 of 3- (4-chlorophenyl) -3-methyl-1- (methyl-phenyl-amino) -5-methylsulfonyl-2,3-dihydro-pyrrol-2-one (compound 60) Produce

상기 실시예 3에서 얻은 화합물 0.81 g(2.0 mmol)을 옥손 1.23 g(2.0 mmol)이 용해된 메탄올 10 ml에 넣고 상온에서 3 시간동안 교반하였다. 반응물을 얼음물 20 g에 가하고 디클로로메탄 30 ml로 2회 추출하였다. 유기층을 물 100 ml로 세척한 다음 무수 황산나트륨으로 건조, 여과 및 농축하였다. 생성물을 칼럼 크로마토그래피(용출액,n-헥산:에틸아세테이트=3:1)로 정제하여 표제화합물 0.77 g (수율 92 %)을 얻었다.0.81 g (2.0 mmol) of the compound obtained in Example 3 was added to 10 ml of methanol in which 1.23 g (2.0 mmol) of oxone was dissolved, followed by stirring at room temperature for 3 hours. The reaction was added to 20 g of ice water and extracted twice with 30 ml of dichloromethane. The organic layer was washed with 100 ml of water and then dried over anhydrous sodium sulfate, filtered and concentrated. The product was purified by column chromatography (eluent, n-hexane: ethyl acetate = 3: 1) to give 0.77 g (yield 92%) of the title compound.

1H NMR(200MHz, CDCl3) δ 7.69-7.17(m, 5H, aromatic), 7.10-6.85 (m,4H, aromatic), 5.17 (s, 1H), 5.13 (s, 1H), 3.28 (d, J= 12Hz, 3H, N-Me), 3.12 (s, 3H, SO2Me), 1.62 (s, 3H, Me). 1 H NMR (200 MHz, CDCl 3) δ 7.69-7.17 (m, 5H, aromatic), 7.10-6.85 (m, 4H, aromatic), 5.17 (s, 1H), 5.13 (s, 1H), 3.28 (d, J = 12 Hz, 3H, N-Me), 3.12 (s, 3H, SO 2 Me), 1.62 (s, 3H, Me).

상기 실시예 1 내지 4에서와 동일한 방법으로 표 1 및 2에 기재된 본 발명의 화합물들을 합성하였으며, 이 화합물들의1H NMR 스펙트럼 결과는 각각 표 3 및 표 4와 같다.The compounds of the present invention described in Tables 1 and 2 were synthesized in the same manner as in Examples 1 to 4, and the 1 H NMR spectra of these compounds were shown in Tables 3 and 4, respectively.

화합물 번호Compound number 1H NMR (CDCl3, 200MHz) 1 H NMR (CDCl 3 , 200 MHz) 99 7.12-6.89 (m, 4H), 6.80-6.72 (m, 2H), 6.68-6.60(m, 2H), 2.89 (dd, J= 47.4, 17.8 Hz, 2H), 1.58 (s, 3H)7.12-6.89 (m, 4H), 6.80-6.72 (m, 2H), 6.68-6.60 (m, 2H), 2.89 (dd, J = 47.4, 17.8 Hz, 2H), 1.58 (s, 3H) 1010 7.16-7.00 (m, 3H), 6.95-6.80 (m, 3H), 6.74-6.71(m, 2H), 2.87 (dd, J= 56.4, 18.8 Hz, 2H), 1.63 (s, 3H)7.16-7.00 (m, 3H), 6.95-6.80 (m, 3H), 6.74-6.71 (m, 2H), 2.87 (dd, J = 56.4, 18.8 Hz, 2H), 1.63 (s, 3H) 1111 7.14-7.00 (m, 3H), 6.86-6.77(m, 3H), 6.75-6.71(m, 2H), 2.80 (s, 3H), 2.64 (dd, J= 55.8, 16.7 Hz, 2H), 1.54 (s, 3H)7.14-7.00 (m, 3H), 6.86-6.77 (m, 3H), 6.75-6.71 (m, 2H), 2.80 (s, 3H), 2.64 (dd, J = 55.8, 16.7 Hz, 2H), 1.54 ( s, 3 H) 1212 7.16-7.00 (m, 3H), 6.90-6.82 (m, 3H), 6.77-6.70(m, 2H), 2.76 (s, 3H), 2.64 (dd, J= 45.0, 15.7 Hz, 2H), 1.61 (s, 3H)7.16-7.00 (m, 3H), 6.90-6.82 (m, 3H), 6.77-6.70 (m, 2H), 2.76 (s, 3H), 2.64 (dd, J = 45.0, 15.7 Hz, 2H), 1.61 ( s, 3 H) 1313 7.33 (s, 4H), 7.28-7.16 (m, 2H), 6.99-6.90 (m, 1H), 6.72-6.67(m, 2H), 2.95 (dd, J= 50.6, 18.8 Hz, 2H), 1.60 (s, 3H)7.33 (s, 4H), 7.28-7.16 (m, 2H), 6.99-6.90 (m, 1H), 6.72-6.67 (m, 2H), 2.95 (dd, J = 50.6, 18.8 Hz, 2H), 1.60 ( s, 3 H) 1414 7.35 (s, 4H), 7.30-7.17 (m, 2H), 7.03-6.95 (m, 1H), 6.77-6.73 (m, 2H), 2.99 (ddd, J= 56.2, 19.2, 1.0 Hz, 2H), 1.76 (s, 3H)7.35 (s, 4H), 7.30-7.17 (m, 2H), 7.03-6.95 (m, 1H), 6.77-6.73 (m, 2H), 2.99 (ddd, J = 56.2, 19.2, 1.0 Hz, 2H), 1.76 (s, 3 H) 1515 7.32 (s, 4H), 7.25-7.18 (m, 2H), 6.92-6.84 (m, 1H), 6.69-6.65(m, 2H), 3.27 (s, 3H), 2.99 (dd, J= 49.8, 18.7 Hz, 2H), 1.68 (s, 3H)7.32 (s, 4H), 7.25-7.18 (m, 2H), 6.92-6.84 (m, 1H), 6.69-6.65 (m, 2H), 3.27 (s, 3H), 2.99 (dd, J = 49.8, 18.7 Hz, 2H), 1.68 (s, 3H) 1717 7.40-7.21 (m, 4H), 7.00-6.88 (m, 2H), 6.79-6.69(m, 3H), 3.20 (dd, J= 55.9, 18.0 Hz, 2H), 1.64 (s, 3H)7.40-7.21 (m, 4H), 7.00-6.88 (m, 2H), 6.79-6.69 (m, 3H), 3.20 (dd, J = 55.9, 18.0 Hz, 2H), 1.64 (s, 3H) 1818 7.42-7.20 (m, 4H), 7.00-6.84 (m, 2H), 6.74-6.66(m, 3H), 3.14 (dd, J= 60.5, 17.8 Hz, 2H), 1.69 (s, 3H)7.42-7.20 (m, 4H), 7.00-6.84 (m, 2H), 6.74-6.66 (m, 3H), 3.14 (dd, J = 60.5, 17.8 Hz, 2H), 1.69 (s, 3H) 1919 7.50-7.15 (m, 4H), 7.02-6.90 (m, 2H), 6.82-6.71(m, 3H), 3.70 (s, 3H), 3.18 (dd, J= 70.4, 18.8 Hz, 2H), 1.65 (s, 3H)7.50-7.15 (m, 4H), 7.02-6.90 (m, 2H), 6.82-6.71 (m, 3H), 3.70 (s, 3H), 3.18 (dd, J = 70.4, 18.8 Hz, 2H), 1.65 ( s, 3 H) 2020 7.48-7.18 (m, 4H), 7.05-6.95 (m, 2H), 6.84-6.70(m, 3H), 3.66 (s, 3H), 3.22 (dd, J= 65.2, 19.7 Hz, 2H), 1.71 (s, 3H)7.48-7.18 (m, 4H), 7.05-6.95 (m, 2H), 6.84-6.70 (m, 3H), 3.66 (s, 3H), 3.22 (dd, J = 65.2, 19.7 Hz, 2H), 1.71 ( s, 3 H) 2121 7.60-7.43 (m, 2H) 7.20-7.00 (m, 4H), 6.88-6.60 (m, 4H), 3.34 (dd, J= 68.8, 19.2 Hz, 2H), 1.60 (s, 3H)7.60-7.43 (m, 2H) 7.20-7.00 (m, 4H), 6.88-6.60 (m, 4H), 3.34 (dd, J = 68.8, 19.2 Hz, 2H), 1.60 (s, 3H) 2222 7.58-7.42 (m, 2H) 7.24-7.11 (m, 4H), 6.90-6.72 (m, 4H), 3.30 (dd, J= 48.58, 18.2 Hz, 2H), 1.70 (s, 3H)7.58-7.42 (m, 2H) 7.24-7.11 (m, 4H), 6.90-6.72 (m, 4H), 3.30 (dd, J = 48.58, 18.2 Hz, 2H), 1.70 (s, 3H) 2323 7.50-7.20 (m, 2H), 7.12-7.00 (m, 4H), 6.90-6.82(m, 4H), 3.68 (s, 3H), 3.38 (dd, J= 75.6, 19.0 Hz, 2H), 1.63 (s, 3H)7.50-7.20 (m, 2H), 7.12-7.00 (m, 4H), 6.90-6.82 (m, 4H), 3.68 (s, 3H), 3.38 (dd, J = 75.6, 19.0 Hz, 2H), 1.63 ( s, 3 H) 2424 7.60-7.32 (m, 2H), 7.25-7.00 (m, 4H), 6.95-6.80(m, 4H), 3.66 (s, 3H), 3.49 (dd, J= 42.4, 16.4 Hz, 2H), 1.71 (s, 3H)7.60-7.32 (m, 2H), 7.25-7.00 (m, 4H), 6.95-6.80 (m, 4H), 3.66 (s, 3H), 3.49 (dd, J = 42.4, 16.4 Hz, 2H), 1.71 ( s, 3 H) 2525 7.43-7.02 (m, 9H) 6.90-6.80 (m, 5H), 4.98 (s, 2H), 3.06 (dd, J= 70.4, 18.8 Hz, 2H), 1.70 (s, 3H)7.43-7.02 (m, 9H) 6.90-6.80 (m, 5H), 4.98 (s, 2H), 3.06 (dd, J = 70.4, 18.8 Hz, 2H), 1.70 (s, 3H) 2626 7.50-7.10 (m, 9H) 7.00-6.85 (m, 5H), 5.02 (s, 2H), 3.10 (dd, J= 65.0, 18.4 Hz, 2H), 1.78 (s, 3H)7.50-7.10 (m, 9H) 7.00-6.85 (m, 5H), 5.02 (s, 2H), 3.10 (dd, J = 65.0, 18.4 Hz, 2H), 1.78 (s, 3H) 2727 7.49-7.12 (m, 9H) 7.04-6.82 (m, 5H), 4.99 (s, 2H), 3.30 (s, 3H), 3.04 (dd, J= 75.4, 17.8 Hz, 2H), 1.68 (s, 3H)7.49-7.12 (m, 9H) 7.04-6.82 (m, 5H), 4.99 (s, 2H), 3.30 (s, 3H), 3.04 (dd, J = 75.4, 17.8 Hz, 2H), 1.68 (s, 3H ) 2828 7.60-7.25 (m, 9H) 7.12-6.92 (m, 5H), 5.00 (s, 2H), 3.46 (s, 3H), 3.08 (dd, J= 70.0, 19.4 Hz, 2H), 1.75 (s, 3H)7.60-7.25 (m, 9H) 7.12-6.92 (m, 5H), 5.00 (s, 2H), 3.46 (s, 3H), 3.08 (dd, J = 70.0, 19.4 Hz, 2H), 1.75 (s, 3H )

2929 7.63-7.20 (m, 8H) 7.12-6.95 (m, 5H), 4.99 (s, 2H), 3.17 (dd, J= 65.4, 18.6 Hz, 2H), 1.64 (s, 3H)7.63-7.20 (m, 8H) 7.12-6.95 (m, 5H), 4.99 (s, 2H), 3.17 (dd, J = 65.4, 18.6 Hz, 2H), 1.64 (s, 3H) 3030 7.59-7.15 (m, 8H) 7.07-6.92 (m, 5H), 5.00 (s, 2H), 3.20 (dd, J= 72.0, 19.8 Hz, 2H), 1.72 (s, 3H)7.59-7.15 (m, 8H) 7.07-6.92 (m, 5H), 5.00 (s, 2H), 3.20 (dd, J = 72.0, 19.8 Hz, 2H), 1.72 (s, 3H) 3131 7.52-7.22 (m, 8H) 7.13-6.90 (m, 5H), 5.01 (s, 2H), 3.47 (s, 3H), 3.10 (dd, J= 45.4, 16.2 Hz, 2H), 1.60 (s, 3H)7.52-7.22 (m, 8H) 7.13-6.90 (m, 5H), 5.01 (s, 2H), 3.47 (s, 3H), 3.10 (dd, J = 45.4, 16.2 Hz, 2H), 1.60 (s, 3H ) 3232 7.65-7.30 (m, 8H) 7.20-7.02 (m, 5H), 4.97 (s, 2H), 3.53 (s, 3H), 3.07 (dd, J= 52.8, 18.0.2 Hz, 2H), 1.68 (s, 3H)7.65-7.30 (m, 8H) 7.20-7.02 (m, 5H), 4.97 (s, 2H), 3.53 (s, 3H), 3.07 (dd, J = 52.8, 18.0.2 Hz, 2H), 1.68 (s , 3H) 3333 7.54-7.47 (m, 2H) 7.32-7.14 (m, 6H), 7.03-6.89 (m, 3H), 6.80-6.64 (m, 2H), 5.12 (s, 2H), 3.04 (dd, J= 65.4, 18.6 Hz, 2H), 1.75 (s, 3H)7.54-7.47 (m, 2H) 7.32-7.14 (m, 6H), 7.03-6.89 (m, 3H), 6.80-6.64 (m, 2H), 5.12 (s, 2H), 3.04 (dd, J = 65.4, 18.6 Hz, 2H), 1.75 (s, 3H) 3434 7.60-7.51 (m, 2H) 7.35-7.20(m, 6H), 7.09-6.93 (m, 3H), 6.82-6.65 (m, 2H), 5.10 (s, 2H), 3.14 (dd, J= 70.4, 19.6 Hz, 2H), 1.78 (s, 3H)7.60-7.51 (m, 2H) 7.35-7.20 (m, 6H), 7.09-6.93 (m, 3H), 6.82-6.65 (m, 2H), 5.10 (s, 2H), 3.14 (dd, J = 70.4, 19.6 Hz, 2H), 1.78 (s, 3H) 3535 7.57-7.48 (m, 2H) 7.35-7.18 (m, 6H), 7.05-6.90 (m, 3H), 6.82-6.60 (m, 2H) 4.98 (s, 2H), 3.52 (s, 3H), 3.05 (dd, J= 70.2, 19.0 Hz, 2H), 1.62 (s, 3H)7.57-7.48 (m, 2H) 7.35-7.18 (m, 6H), 7.05-6.90 (m, 3H), 6.82-6.60 (m, 2H) 4.98 (s, 2H), 3.52 (s, 3H), 3.05 ( dd, J = 70.2, 19.0 Hz, 2H), 1.62 (s, 3H) 3636 7.63-7.55 (m, 2H) 7.48-7.25 (m, 6H), 7.14-6.99 (m, 3H), 6.90-6.78 (m, 2H) 5.01 (s, 2H), 3.64 (s, 3H), 3.10 (dd, J= 55.2, 14.8 Hz, 2H), 1.69 (s, 3H)7.63-7.55 (m, 2H) 7.48-7.25 (m, 6H), 7.14-6.99 (m, 3H), 6.90-6.78 (m, 2H) 5.01 (s, 2H), 3.64 (s, 3H), 3.10 ( dd, J = 55.2, 14.8 Hz, 2H), 1.69 (s, 3H) 3737 7.30-7.06 (m, 8H), 7.00-6.89 (m, 3H), 6.76-6.69 (m, 2H), 5.00 (s, 2H), 3.25 (dd, J= 65.8, 17.4 Hz, 2H), 2.34 (s, 3H), 1.60(s, 3H)7.30-7.06 (m, 8H), 7.00-6.89 (m, 3H), 6.76-6.69 (m, 2H), 5.00 (s, 2H), 3.25 (dd, J = 65.8, 17.4 Hz, 2H), 2.34 ( s, 3H), 1.60 (s, 3H) 3838 7.27-7.07 (m, 8H), 6.94-6.89 (m, 3H), 6.69-6.65 (m, 2H), 4.95 (s, 2H), 3.39 (dd, J= 72.2, 19.0 Hz, 2H), 2.31 (s, 3H), 1.65(s, 3H)7.27-7.07 (m, 8H), 6.94-6.89 (m, 3H), 6.69-6.65 (m, 2H), 4.95 (s, 2H), 3.39 (dd, J = 72.2, 19.0 Hz, 2H), 2.31 ( s, 3H), 1.65 (s, 3H) 3939 7.25-7.00 (m, 8H), 6.99-6.80 (m, 3H), 6.70-6.62 (m, 2H), 4.98 (s, 2H), 3.30 (s, 3H), 3.03 (dd, J= 68.8, 19.4 Hz, 2H), 2.32 (s, 3H), 1.68(s, 3H)7.25-7.00 (m, 8H), 6.99-6.80 (m, 3H), 6.70-6.62 (m, 2H), 4.98 (s, 2H), 3.30 (s, 3H), 3.03 (dd, J = 68.8, 19.4 Hz, 2H), 2.32 (s, 3H), 1.68 (s, 3H) 4040 7.33-7.13 (m, 8H), 6.99-6.83 (m, 3H), 6.67-6.64 (m, 2H), 4.99 (s, 2H), 3.27 (s, 3H), 3.03 (dd, J= 61.8, 18.2 Hz, 2H), 2.34 (s, 3H), 1.72(s, 3H)7.33-7.13 (m, 8H), 6.99-6.83 (m, 3H), 6.67-6.64 (m, 2H), 4.99 (s, 2H), 3.27 (s, 3H), 3.03 (dd, J = 61.8, 18.2 Hz, 2H), 2.34 (s, 3H), 1.72 (s, 3H) 4141 7.35-7.20 (m, 8H), 7.10-6.85 (m, 3H), 6.67-6.60 (m, 2H), 5.01 (s, 2H), 3.40 (dd, J= 68.8, 18.6 Hz, 2H), 2.30 (s, 3H), 1.65(s, 3H)7.35-7.20 (m, 8H), 7.10-6.85 (m, 3H), 6.67-6.60 (m, 2H), 5.01 (s, 2H), 3.40 (dd, J = 68.8, 18.6 Hz, 2H), 2.30 ( s, 3H), 1.65 (s, 3H) 4242 7.38-7.21 (m, 8H), 7.18-6.91 (m, 3H), 6.73-6.70 (m, 2H), 5.00 (s, 2H), 3.45 (dd, J= 71.6, 19.2 Hz, 2H), 2.34 (s, 3H), 1.71(s, 3H)7.38-7.21 (m, 8H), 7.18-6.91 (m, 3H), 6.73-6.70 (m, 2H), 5.00 (s, 2H), 3.45 (dd, J = 71.6, 19.2 Hz, 2H), 2.34 ( s, 3H), 1.71 (s, 3H) 4343 7.35-7.12 (m, 8H), 6.99-6.87 (m, 3H), 6.72-6.65 (m, 3H), 5.04 (s, 2H), 3.31 (s, 3H), 3.07 (dd, J= 67.2, 19.8 Hz, 2H), 2.35 (s, 3H), 1.72 (s, 3H)7.35-7.12 (m, 8H), 6.99-6.87 (m, 3H), 6.72-6.65 (m, 3H), 5.04 (s, 2H), 3.31 (s, 3H), 3.07 (dd, J = 67.2, 19.8 Hz, 2H), 2.35 (s, 3H), 1.72 (s, 3H) 4444 7.42-7.20 (m, 8H), 7.12-7.00 (m, 3H), 6.84-6.70 (m, 3H), 5.07 (s, 2H), 3.31 (s, 3H), 3.08 (dd, J= 45.2, 14.3 Hz, 2H), 2.40 (s, 3H), 1.80 (s, 3H)7.42-7.20 (m, 8H), 7.12-7.00 (m, 3H), 6.84-6.70 (m, 3H), 5.07 (s, 2H), 3.31 (s, 3H), 3.08 (dd, J = 45.2, 14.3 Hz, 2H), 2.40 (s, 3H), 1.80 (s, 3H) 4545 7.42-7.18 (m, 8H), 7.05-6.90 (m, 3H), 6.82-6.69 (m, 2H), 5.01 (s, 2H), 3.74 (s, 3H), 3.25 (dd, J= 67.8, 17.4 Hz, 2H), 1.60(s, 3H)7.42-7.18 (m, 8H), 7.05-6.90 (m, 3H), 6.82-6.69 (m, 2H), 5.01 (s, 2H), 3.74 (s, 3H), 3.25 (dd, J = 67.8, 17.4 Hz, 2H), 1.60 (s, 3H) 4646 7.47-7.15 (m, 8H), 7.04-6.89 (m, 3H), 6.75-6.68 (m, 2H), 4.98 (s, 2H), 3.85 (s, 3H), 3.27(dd, J= 72.8, 19.0 Hz, 2H), 1.65(s, 3H)7.47-7.15 (m, 8H), 7.04-6.89 (m, 3H), 6.75-6.68 (m, 2H), 4.98 (s, 2H), 3.85 (s, 3H), 3.27 (dd, J = 72.8, 19.0 Hz, 2H), 1.65 (s, 3H) 4747 7.43-7.20 (m, 8H), 6.99-6.76 (m, 3H), 6.70-6.62 (m, 2H), 4.98 (s, 2H), 3.78 (s, 3H), 3.03 (dd, J= 67.5, 18.4 Hz, 2H), 1.68(s, 3H)7.43-7.20 (m, 8H), 6.99-6.76 (m, 3H), 6.70-6.62 (m, 2H), 4.98 (s, 2H), 3.78 (s, 3H), 3.03 (dd, J = 67.5, 18.4 Hz, 2H), 1.68 (s, 3H) 4848 7.57-7.29 (m, 8H), 7.10-6.99 (m, 3H), 6.87-6.72 (m, 2H), 4.99 (s, 2H), 3.80 (s, 3H), 3.10 (dd, J= 60.8, 18.2 Hz, 2H), 2.44 (s, 3H), 1.72(s, 3H)7.57-7.29 (m, 8H), 7.10-6.99 (m, 3H), 6.87-6.72 (m, 2H), 4.99 (s, 2H), 3.80 (s, 3H), 3.10 (dd, J = 60.8, 18.2 Hz, 2H), 2.44 (s, 3H), 1.72 (s, 3H) 5353 7.40-7.26 (m, 3H), 7.14-6.98 (m, 3H), 6.72-6.67(m, 2H), 2.96 (dd, J= 51.6, 19.8 Hz, 2H), 1.54 (s, 3H)7.40-7.26 (m, 3H), 7.14-6.98 (m, 3H), 6.72-6.67 (m, 2H), 2.96 (dd, J = 51.6, 19.8 Hz, 2H), 1.54 (s, 3H)

5454 7.37-7.27 (m, 3H), 7.16-6.94 (m, 3H), 6.80-6.71(m, 2H), 2.98 (dd, J= 51.0, 19.8 Hz, 2H), 1.62 (s, 3H)7.37-7.27 (m, 3H), 7.16-6.94 (m, 3H), 6.80-6.71 (m, 2H), 2.98 (dd, J = 51.0, 19.8 Hz, 2H), 1.62 (s, 3H) 5555 7.44-7.28 (m, 3H), 7.16-6.99 (m, 3H), 6.85-6.77(m, 2H), 3.31 (s, 3H), 3.01 (dd, J= 48.8, 15.7 Hz, 2H), 1.60 (s, 3H)7.44-7.28 (m, 3H), 7.16-6.99 (m, 3H), 6.85-6.77 (m, 2H), 3.31 (s, 3H), 3.01 (dd, J = 48.8, 15.7 Hz, 2H), 1.60 ( s, 3 H) 5656 7.42-7.18 (m, 3H), 7.02-6.84 (m, 3H), 6.74-6.65(m, 2H), 3.30 (s, 3H) 3.16 (dd, J= 42.0, 19.2 Hz, 2H),, 1.68 (s, 3H)7.42-7.18 (m, 3H), 7.02-6.84 (m, 3H), 6.74-6.65 (m, 2H), 3.30 (s, 3H) 3.16 (dd, J = 42.0, 19.2 Hz, 2H), 1.68 ( s, 3 H)

5757 7.53-7.22 (m, 5H), 6.98- 6.67 (m, 4H), 5.22 (s, 1H), 5.19 (s, 3H), 2.39 (s, 3H), 1.28 (s, 3H)7.53-7.22 (m, 5H), 6.98-6.67 (m, 4H), 5.22 (s, 1H), 5.19 (s, 3H), 2.39 (s, 3H), 1.28 (s, 3H) 5858 7.54-7.11(m, 5H), 6.98-6.67 (m, 4H), 5.16 (s, 1H), 5.13 (s, 1H), 3.26 (d, J= 11Hz, 3H), 2.31 (s, 3H), 1.62 (s, 3H)7.54-7.11 (m, 5H), 6.98-6.67 (m, 4H), 5.16 (s, 1H), 5.13 (s, 1H), 3.26 (d, J = 11 Hz, 3H), 2.31 (s, 3H), 1.62 (s, 3 H) 5959 7.69-7.17(m, 5H), 7.10-6.85 (m, 4H), 5.17 (s, 1H), 5.13 (s, 1H), 3.28 (d, J= 12Hz, 3H), 3.12 (s, 3H), 1.62 (s, 3H)7.69-7.17 (m, 5H), 7.10-6.85 (m, 4H), 5.17 (s, 1H), 5.13 (s, 1H), 3.28 (d, J = 12 Hz, 3H), 3.12 (s, 3H), 1.62 (s, 3 H)

제조된 본 발명의 화합물의 살균 활성을 다음과 같이 측정하였다. 즉, 식물 병원균에 대한 예방 효과를 조사하기 위하여, 시험 화합물 50 mg을 아세톤 10 ml에 용해시킨 후 트윈 20(Tween 20) 250 ppm 수용액 140 ml를 첨가하여 그 농도가 250 ppm이 되게 조정한 다음, 이 용액 50 ml를 일정 크기의 기주 식물의 엽면에 살포하였다. 약제가 살포된 식물을 실내온도에서 24 시간동안 방치하여 용매 및 물을 휘산시킨 후 여기에 식물 병원균을 접종하였다. 아래의 시험예의 병원균 균주들은 야생의 식물체에서 직접 채취하여 순수 교대 배양하여 사용하였다. 모든 실험은 2 회 반복 실시하였다.The bactericidal activity of the prepared compounds of the present invention was measured as follows. That is, to investigate the preventive effect against plant pathogens, 50 mg of the test compound was dissolved in 10 ml of acetone, and then 140 ml of 250 ppm aqueous Tween 20 solution was added to adjust the concentration to 250 ppm. 50 ml of this solution were sprayed onto the foliar of a certain size of host plant. The plants sprayed with the medicament were left at room temperature for 24 hours to volatilize the solvent and water, and then inoculated there with plant pathogens. The pathogen strains of the test examples below were taken directly from wild plants and used by pure alternation culture. All experiments were repeated twice.

시험예 1: 벼 도열병에 대한 살균 효과Test Example 1 Bactericidal Effect on Rice Blast

벼 도열병의 병원균(Pyricularia oryzae) 균주를 쌀겨 한천배지(쌀겨 20 g,덱스트로스 10 g, 한천 15 g, 증류수 1 L)에 접종한 후 26oC 배양기에서 2 주동안 배양하였다. 병원균이 자란 배지의 표면을 고무 쓸개로 긁어 기중균사를 제거하고 형광등이 켜진 선반(25-28oC)에서 48 시간동안 두어 포자를 형성시켰다. 병균접종은 형성시킨 분생 포자를 멸균 증류수를 이용하여 106포자/ml의 일정농도의 포자현탁액을 만든 후 벼 도열병에 감수성인 낙동벼(3-4엽기)에 흘러내릴 정도로 충분히 분무하여 병원균을 접종하였다. 접종된 벼는 습실상에서 암상태로 24 시간 동안 놓아둔 뒤, 상대습도 90 % 이상이고 온도 26 ± 2oC인 항온항습실에서 5 일 동안 둔 다음 발병 면적을 측정하였다. 발병 조사는 3-4 엽기 벼의 최상위엽 바로 밑의 완전 전개된 잎에 형성된 병반면적을 표준 이병면적율 대비표에 준하여 조사하였다. Pyricularia oryzae strains of rice blast were inoculated in rice bran agar medium (rice bran 20 g, dextrose 10 g, agar 15 g, distilled water 1 L) and incubated for 2 weeks in a 26 o C incubator. The surface of the medium in which the pathogen was grown was scraped off with a rubber gallbladder to remove aerial hyphae and placed on a fluorescent lighted shelf (25-28 o C) for 48 hours to form spores. The bacterial inoculation was inoculated with pathogens by spraying the conidia to form a spore suspension of 10 6 spores / ml using sterile distilled water, and then spraying enough to flow into Nakdong rice (3-4 leaves) susceptible to rice blasting. . The inoculated rice was left in the dark for 24 hours, and then placed for 5 days in a constant temperature and humidity room with a relative humidity of 90% or more and a temperature of 26 ± 2 o C. The incidence was investigated by examining the lesion area formed on the fully developed leaf just below the top leaf of 3-4 leafy rice, according to the standard disease area ratio comparison table.

시험예 2: 벼잎집무늬 마름병에 대한 살균효과Test Example 2: bactericidal effect on rice leaf blight blight

적당한 양의 밀기울을 1L 배양병에 넣고 멸균한 후, 감자 한천배지(PDA)에서 3 일간 자란 벼입집무늬 마름병의 병원균(Rhizoctonia solani)의 한천 조각을 접종한 다음 25oC에서 10일동안 배양하였다. 배양된 균사덩어리를 적당히 잘게 마쇄하여 2-3 엽기의 낙동벼가 자란 포트(5 cm)에 고르게 접종하여 습실상(28 ± 1oC)에서 배양 후 상대습도 80 % 이상인 항온항습실에서 5 일간 둔 다음 병 발생을 조사하였다. 발병 조사는 2-3 엽기 유묘의 잎집에 발병된 병반의 면적율을 잎집 면적에 대한 병반면적이 차지하는 비율을 기준으로 하여 작성한 이병 면적율 대비표에 준하여 조사하였다.After the appropriate amount of bran was put into a 1L culture bottle and sterilized, agar pieces of Rhizoctonia solani ( Rhizoctonia solani ) grown in potato agar medium (PDA) for 3 days were inoculated and incubated at 25 o C for 10 days. . After cultivating the mycelial cultivation moderately finely, inoculate evenly into the pot (5 cm) in which Nakdong rice of 2-3 leaves was grown, and incubate in a wet room (28 ± 1 o C), and leave it for 5 days in a constant temperature and humidity room with a relative humidity of 80% or more. Disease occurrence was investigated. The incidence was investigated according to the comparison table of disease area ratios based on the ratio of lesion area to leaf area of leaf lesions.

시험예 3: 오이 잿빛곰팡이병에 대한 살균 효과Test Example 3: bactericidal effect on cucumber gray mold

오이 잿빛곰팡이병로부터 분리한 균주(Botrytis cinerea)를 감자한천배지(PDA)에 접종하고 25oC의 배양기에서 광암상태하에 15일동안 배양하여 포자를 형성시켰다. 배지에 플레이트당 10 ml의 증류수를 넣고 붓으로 포자를 긁은 후 가제로 걸러서 포자를 수확한 다음 포자 농도가 106개/ml가 되도록 한 후 1엽기 오이에 흘러내릴 정도로 분무 접종하였다. 이를 20oC 습실상에서 3일간 습실 처리한 후 본엽 1 엽의 병반 면적율을 조사하였다.Strains isolated from cucumber gray mold disease ( Botrytis cinerea ) were inoculated in potato agar medium (PDA) and incubated in a 25 ° C. incubator for 15 days to form spores. Enough distilled water of 10 ml per plate on medium brush scratched after the spores were harvested by filtering the spores in spore gauze then a concentration of 10 6 / ml and then such that the flow down to the 1 leaf stage cucumber was inoculated spray. After 3 days of wet treatment on 20 o C wet room, the leaf area ratio of the first leaf was investigated.

시험예 4: 토마토역병에 대한 살균 효과Test Example 4 bactericidal effect against tomato late blight

토마토역병의 병원균(Phytophthora infestans) 균주를 V-8 쥬스 한천배지(V-8 쥬스 200 ml, 탄산칼륨 4.5 g, 한천 15 g, 증류수 800 ml)에 접종하고 20oC에서 16 시간 광처리 및 8 시간 암처리하여 14 일동안 배양하여 포자를 형성시켰다. 이 플레이트에 멸균 증류수를 넣고 흔들어서 균총으로부터 유주자낭을 떼어낸 후 4 겹 헝겊조각을 사용하여 유주자낭을 수확하였다. 이 유주자낭의 농도를 105개/ml로조정하여, 토마토 유묘에 분무접종하여 20oC 습실상에서 1 일동안 습실 처리한 후 20 ℃, 상대습도 80 % 이상의 항온항습실로 옮겨 4 일동안 발병시킨 다음 토마토 1 엽과 2 엽의 병반면적율(%)을 조사하였다. Phytophthora infestans strains were inoculated into V-8 juice agar medium (V-8 juice 200 ml, potassium carbonate 4.5 g, agar 15 g, distilled water 800 ml) and light treated at 20 o C for 16 hours and 8 hours. Spores were formed by incubation for 14 days in the dark. Sterile distilled water was added to the plate and shaken to separate the zygote sac from the flora, and then the zygote sac was harvested using a 4-ply piece of cloth. After adjusting the concentration of lactose sac to 10 5 pcs / ml, it was sprayed with tomato seedlings for 1 day in a 20 o C chamber, then transferred to a constant temperature and humidity chamber at 20 ° C. and a relative humidity of 80% or higher, and then developed for 4 days. The lesion area (%) of one and two leaves of tomato was investigated.

시험예 5 : 밀 붉은 녹병에 대한 살균 효과Test Example 5: bactericidal effect against wheat red rust

밀 붉은 녹병의 병원균(Puccinia recondita) 균주를 실험실에서 식물체에 직접 계대 배양하여 사용하였다. 균주의 계대 배양 및 약효 조사를 위해 일회용 포트(직경 : 6.5 cm)에 15 립씩의 밀종자(은파)를 파종한 후 온실에서 7 일동안 재배한 1 엽기의 밀에 포자를 털어서 접종하였다. 접종한 1 엽기의 밀은 20oC의 습실상에서 1 일간 습실 처리한 후에 상대습도가 70 % 인 20oC의 항온항습실로 옮겨서 발병을 유도하고 접종 10 일 후에 발병을 조사하였다. 발병조사는 포자를 접종한 지 10 일 후에 병반 면적율을 조사하였다. Puccinia recondita strains of wheat red rust were used for passaging directly to plants in a laboratory. For seeding culture and investigation of efficacy, 15 seed grains (silver onions) were sown in a disposable pot (diameter: 6.5 cm), and then spores were inoculated by sprinkling one leafy wheat grown for 7 days in a greenhouse. Wheat inoculated leaf stage 1 was examined after the onset of the disease induced 10 transferred to a 20 o C in a wet substance of seupsil one days after treatment and a relative humidity of 70% 20 o C constant temperature hangseupsil inoculated days. The onset was to investigate the lesion area rate 10 days after inoculation of spores.

시험예 6: 보리 흰가루 병에 대한 살균 효과Test Example 6: bactericidal effect on barley flour bottle

보리 흰가루병의 병원균(Erysiphe graminis f.sp.hordei) 균주은 실험실에서 계대 배양하여 사용하였다. 균주의 계대 배양 및 약효 조사를 위해서 일회용 포트(직경: 6.5 cm)에 15 립씩의 보리종자(동보리 1 호)를 파종하여, 온실(25±5℃)에서 7 일간 재배한 1 엽기의 보리에 흰가루병 포자를 털어 접종하여 발병시켰다. 위와 같은 방법으로 접종된 식물을 상대습도 50 %, 22-24 ℃ 정도의 항온항습실에 옮겨 7 일간 발병을 유도한 뒤 병반면적율을 조사하였다. Erysiphe graminis f.sp.hordei strain of barley powdery mildew was used by passage in the laboratory. For passaging of the strain and investigation of efficacy, 15 seeded barley seeds (East barley No. 1) were sown in a disposable pot (diameter: 6.5 cm), and grown on a single barley barley grown for 7 days in a greenhouse (25 ± 5 ° C). Powdered spore spores were inoculated and inoculated. The inoculated plants were inoculated in the same manner as above, and the relative humidity of 50% and 22-24 ℃ was transferred to a constant temperature and humidity room to induce the onset for 7 days and then the area ratio of the lesions was investigated.

상기 시험예 1 내지 6의 시험결과로부터 하기 수학식 1에 따라 방제가(Control Value)를 산출하였다.From the test results of Test Examples 1 to 6, a control value was calculated according to Equation 1 below.

산출된 방제가에 따라 활성지수(++++: 방제가 81-100%, +++: 방제가 61-80%, ++: 방제가 41-60%, +: 방제가 21-40%, -: 방제가 0-20%)를 결정하였으며, 그 결과는 표 5와 같다.According to the calculated control value, the activity index (++++: 81-100% for control, +++: 61-80% for control, ++: 41-60% for control, +: 21-40% for control ,-: Control was 0-20%), and the results are shown in Table 5.

화합물번호Compound number 벼도열병Rice fever 벼잎집무늬마름병Rice leaf pattern 오이잿빛곰팡이병Cucumber gray mold 토마토역병Tomato plague 밀붉은녹병Wheat Red Rust 보리흰가루병Wheat flour 1313 -- ++++ ++++++ ++++ ++ -- 1414 ++++++++ -- ++ ++++++ ++++++++ ++ 1515 ++++ ++ ++++ ++ ++++++++ ++ 1717 -- ++ -- -- -- -- 1818 ++++++++ ++++ ++ ++++++++ ++++++ -- 1919 -- ++++++ -- ++++ ++++++ -- 2020 -- ++ ++ -- -- -- 2121 ++++++++ ++++ -- ++++ ++++++ -- 2222 ++++++++ ++++ -- ++++ ++ -- 2323 ++++ ++++ -- -- -- -- 2424 -- ++ -- -- -- -- 2525 -- ++ -- ++++ -- -- 2626 -- ++ -- ++ -- -- 2727 -- ++ ++ -- -- -- 2828 -- ++ -- -- -- -- 2929 -- ++++ ++ -- -- -- 3030 -- ++++ -- -- -- -- 3131 -- ++++ ++ -- -- -- 3232 -- ++ ++ -- -- -- 3333 -- -- ++++++ ++++ -- ++ 3434 -- ++++ ++++ ++ ++++ ++++++++ 3535 -- ++++ ++ ++++ ++++++ ++ 3636 -- ++++ -- -- -- -- 3737 -- -- ++ -- -- -- 3838 -- ++++ -- -- ++ -- 3939 -- -- ++++++ -- -- -- 4040 ++ ++++ -- -- -- -- 4141 ++++++++ ++++++ -- ++++++ ++++++++ ++ 4242 -- ++ -- -- -- -- 4343 ++++++ -- -- ++ ++++++ -- 4444 ++++++++ ++++++ -- ++++++ ++++++++ ++ 4545 ++++ -- -- ++++ ++++++++ -- 4646 ++++ -- -- ++ -- -- 4747 -- -- -- -- -- ++++++ 4949 -- ++++ -- ++ ++ -- 5050 -- ++ -- -- -- -- 5151 -- ++++ ++ ++++++++ ++++++ -- 5252 -- -- -- -- -- ++ 5353 -- ++++ -- ++++ ++ ++ 6363 -- ++ -- -- -- --

표 5에서 보듯이, 본 발명의 화합물은 식물 병원균에 대해 살균 활성이 우수하고 항균 스펙트럼이 광범위하다는 것을 알 수 있다.As shown in Table 5, it can be seen that the compounds of the present invention have excellent bactericidal activity against plant pathogens and a broad antibacterial spectrum.

본 발명의 화합물인 일반식(I)의 신규의 1-아미노 피롤리딘 유도체는 우수한 살균 활성 및 광범위한 항균 스펙트럼을 갖고 있어, 농원예용 살균제로 유용하다.The novel 1-amino pyrrolidine derivatives of the general formula (I), which are the compounds of the present invention, have excellent bactericidal activity and broad antibacterial spectrum, and thus are useful as agricultural horticultural fungicides.

Claims (2)

하기 일반식(I)로 표시되는 1-아미노 피롤리딘 유도체.1-amino pyrrolidine derivative represented by the following general formula (I). 화학식 1Formula 1 (I) (I) 상기 식에서,Where R1는 수소원자 또는 C1-C3알킬이고,R 1 is a hydrogen atom or C 1 -C 3 alkyl, R2및 R3는 각각 독립적으로 수소원자, 할로겐원자 또는 C1-C3알킬이고,R 2 and R 3 are each independently a hydrogen atom, a halogen atom or C 1 -C 3 alkyl, Q는또는이다Q is or to be (여기서, R4는 C1-C3알킬이고,Wherein R 4 is C 1 -C 3 alkyl, R5및 R6는 각각 독립적으로 수소 원자, 할로겐 원자, 페녹시, 벤질옥시, 또는 할로겐 원자, C1-C3알킬 또는 C1-C3알콕시로 치환된 벤질옥시이고,R 5 and R 6 are each independently hydrogen atom, halogen atom, phenoxy, benzyloxy, or benzyloxy substituted with halogen atom, C 1 -C 3 alkyl or C 1 -C 3 alkoxy, R7는 C1-C3알킬이고,R 7 is C 1 -C 3 alkyl, X는 산소 또는 황원자이고,X is oxygen or sulfur atom, Y는 산소원자 또는 S(O)n이고,Y is an oxygen atom or S (O) n , n은 0, 1 또는 2이다).n is 0, 1 or 2). 제 1 항에 따른 일반식(I)의 화합물 살균효과량 및 약제학적으로 허용되는 고체 또는 액체 담체를 포함하는, 벼도열병, 벼잎집무늬 마름병, 오이잿빛 곰팡이병, 토마토 역병, 밀붉은녹병 및 보리흰가루병을 일으키는 병원균에 대해 살균 효과를 갖는 농원예용 살균제 조성물.Rice fever, rice leaf blight, cucumber ash fungus, tomato late blight, wheat rust and barley, comprising a bactericidal effective amount of the compound of formula (I) according to claim 1 and a pharmaceutically acceptable solid or liquid carrier Agrohorticultural fungicide composition having a bactericidal effect against pathogens causing powdery mildew.
KR1019980029469A 1998-07-22 1998-07-22 1-amino pyrrolidine derivatives and agricultural and hortic ultural resticide composition comprising same KR100295818B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980029469A KR100295818B1 (en) 1998-07-22 1998-07-22 1-amino pyrrolidine derivatives and agricultural and hortic ultural resticide composition comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980029469A KR100295818B1 (en) 1998-07-22 1998-07-22 1-amino pyrrolidine derivatives and agricultural and hortic ultural resticide composition comprising same

Publications (2)

Publication Number Publication Date
KR20000009203A KR20000009203A (en) 2000-02-15
KR100295818B1 true KR100295818B1 (en) 2001-09-06

Family

ID=19544847

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980029469A KR100295818B1 (en) 1998-07-22 1998-07-22 1-amino pyrrolidine derivatives and agricultural and hortic ultural resticide composition comprising same

Country Status (1)

Country Link
KR (1) KR100295818B1 (en)

Also Published As

Publication number Publication date
KR20000009203A (en) 2000-02-15

Similar Documents

Publication Publication Date Title
US4980363A (en) Novel amide derivatives, processes for production thereof, and agricultural-horticultural fungicide containing them
KR840002290B1 (en) Process for the preparation of n-alkyl-n-acyl arylamine derivatives
US4442117A (en) Homoserine derivatives and their use as microbicides
EA000278B1 (en) Hydroximic acid derivatives and administration thereof
US4287210A (en) Microbicidal meta oxy- and thio-substituted phenylanilines
EP0566175A2 (en) 3,4-Diaryl (5H)-furan-2-one based compounds with fungicide activity
US4500536A (en) Derivatives of N,N'-substituted azolecarboxamide and agricultural and horticultural fungicidal or nematicidal composition containing same as active ingredients
CN116082240A (en) Succinate dehydrogenase inhibitor and synthesis method and application thereof
KR100295818B1 (en) 1-amino pyrrolidine derivatives and agricultural and hortic ultural resticide composition comprising same
HU206329B (en) Process for producing hydroxy-ethyl-triazol derivatives and fungicide compositions containing them as active components and process for utilizing them
KR100427262B1 (en) Fungicidal methoxy acrylate derivatives containing sulfur
KR100501146B1 (en) Triazole derivatives for antifungal composition of agriculture, method of preparing same and antifungal composition comprising same for agriculture
KR100270599B1 (en) Methoxyacrylate or methoxyimno acetate derivatices, method of preparing the same and bacteriocide comprising the same
KR100373705B1 (en) 1-phenyl 4-azolyl pyrazole derivatives, method of preparing the same and antifungal composition comprising the same for agriculture
US4291061A (en) 1H-inden-1-one derivatives, processes for producing them, their use in microbicidal compositions, and for combating microorganisms
KR100392074B1 (en) Thiazole Derivatives with Fungicidal Activity
KR20000002286A (en) Oxazinyl derivatives having superior bacterocidal activity
US4935053A (en) Unsaturated haloacetanilides
KR0146504B1 (en) Azoleamide derivatives
KR100392075B1 (en) Oxazole Derivatives with Fungicidal Activity
RU2067832C1 (en) Method of struggle against fungal infection in plants
KR100417705B1 (en) 4-azoyl-2-quinolinone derivatives and fungicidal composition comprising same
KR100295819B1 (en) New quinoline sulfonium salt derivatives
KR940009934B1 (en) KETENE DITHIO ACETAL Ñß-ANILIDE DERIVATIVES
KR100266964B1 (en) Novel 4-azolyl quinoline derivatives and composition containing the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20070330

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee